Percutaneous Coronary Intervention Market Size, Share and Forecast till 2028 [MarketWatch]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: MarketWatch
The Report Mines study on " Percutaneous Coronary Intervention Market " offers a value chain analysis of the revenue for the forecast period from 2022 to 2028. The study will offer a thorough and comprehensive analysis of the business operations of all the market leaders in this sector as well as their thorough research and history of market development and information about their rivals, including Abbott Vascular,Svelte Medical,Medtronic,Boston Scientific,Cordis,Terumo Medical,Amg International,Asahi Intecc,B. Braun. The global Percutaneous Coronary Intervention market size is projected to reach multi million by 2028, in comparision to 2021, at unexpected CAGR during 2022-2028 (Ask for Sample Report). The study on Percutaneous Coronary Intervention analyses the industry's growth patterns using historical data and projects future growth based on in-depth research reports. The market revenue, market share, growth, trends, and forecasts for the years 2022 to 2028 are the main topic
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.MarketBeat
- Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]Forbes
- Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]Seeking Alpha
- D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website